<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35502998</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-3527</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of psychiatry in medicine</Title>
          <ISOAbbreviation>Int J Psychiatry Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dispensing patterns of mental health medications before and during the COVID-19 pandemic in Alberta, Canada: An interrupted time series analysis.</ArticleTitle>
        <Pagination>
          <StartPage>912174221084818</StartPage>
          <MedlinePgn>912174221084818</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">00912174221084818</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/00912174221084818</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The COVID-19 pandemic has negatively impacted the general population in all aspects of life. Estimates of mental health medication dispensing in Alberta were investigated to elucidate areas of need within mental health and pharmacy practice during the pandemic.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We employed an interrupted time series analysis using linear regression models to estimate community and outpatient medication dispensing trends of 46 medications used to treat mental health disorders. Three parameters were examined. The first was the medication dispensing slope before COVID-19. The second was the immediate effect of COVID-19 on dispensing (i.e., the difference in dispensing rate between the month before and after the first case of COVID-19) and the third was the medication dispensing slope during COVID-19.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Dispensing rates of 61% (<i>n</i> = 34) of the examined medications remained similar before and during the COVID-19 pandemic. However, eight medications (i.e., amitriptyline, escitalopram, fluoxetine, paroxetine, bupropion, desvenlafaxine, venlafaxine, and oxazepam) showed an immediate and significant increase in dispensing rate following the onset of the pandemic that was sustained over the first 13-months of the pandemic.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Initial increases in dispensing patterns of antidepressants may be attributed to a "stockpiling phenomenon" but the sustained higher levels of dispensing suggest an unfavorable shift in the population's mental health. Monitoring of medication dispensing patterns during COVID-19 may serve as a useful indicator of the population's mental health during the current pandemic and better prepare community pharmacists in future pandemic planning, medication dispensing strategies, and care of chronic medical conditions.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ying</LastName>
            <ForeName>Lisa Tl</ForeName>
            <Initials>LT</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine &amp; Dentistry, 3158University of Alberta, Edmonton, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yarema</LastName>
            <ForeName>Mark C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine &amp; Dentistry, 3158University of Alberta, Edmonton, AB, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Poison and Drug Information Service, Alberta Health Services, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Section of Clinical Pharmacology and Toxicology, Alberta Health Services, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, 2129University of Calgary, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bousman</LastName>
            <ForeName>Chad A</ForeName>
            <Initials>CA</Initials>
            <Identifier Source="ORCID">0000-0001-6303-8696</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Medical Genetics, Psychiatry, Physiology &amp; Pharmacology, and Community Health Sciences, 2129University of Calgary, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Alberta Children's Hospital Research Institute, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Mathison Centre for Mental Health Research &amp; Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Psychiatry Med</MedlineTA>
        <NlmUniqueID>0365646</NlmUniqueID>
        <ISSNLinking>0091-2174</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="N">drug dispensing</Keyword>
        <Keyword MajorTopicYN="N">psychotropics</Keyword>
        <Keyword MajorTopicYN="N">trends</Keyword>
      </KeywordList>
      <CoiStatement><b>Declaration of conflicting interests:</b> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>9</Hour>
          <Minute>53</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35502998</ArticleId>
        <ArticleId IdType="pmc">PMC9066241</ArticleId>
        <ArticleId IdType="doi">10.1177/00912174221084818</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>COVID-19 Data Explorer . Our world in data. Retrieved January 29, 2022, from, https://ourworldindata.org/coronavirus-data-explorer (2022).</Citation>
        </Reference>
        <Reference>
          <Citation>Akour A, Elayeh E, Tubeileh R, et al.Role of community pharmacists in medication management during COVID-19 lockdown. Pathog Glob Health 2021; 115(3): 168–177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8079017</ArticleId>
            <ArticleId IdType="pubmed">33573528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Shi L, Que J, et al.The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic. Mol Psy 2021; 26: 1–10.</Citation>
        </Reference>
        <Reference>
          <Citation>Panchal N, Kamal R, Orgera K, et al.. The implications of COVID-19 for mental health and substance use. Kaiser Family Foundation 2020;21. https://www.kff.org/coronavirus-covid-19/issue-brief/the-implications-of-covid-19-for-mental-health-and-substance-use/</Citation>
        </Reference>
        <Reference>
          <Citation>McEwan T. (2020, May 10). More Calls to Mental Health Helplines in Alberta Due to COVID-19 | CBC News. CBC. https://www.cbc.ca/news/canada/edmonton/mental-health-alberta-covid-19-1.5562762</Citation>
        </Reference>
        <Reference>
          <Citation>Express Scripts Canada . Retrieved October 8, 2021, from, https://express-scripts.ca (2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Canada: COVID-19 cases by province . Statista. Retrieved January 29, 2022, from, https://www.statista.com/statistics/1107066/covid19-confirmed-cases-by-province-territory-canada/(2022).</Citation>
        </Reference>
        <Reference>
          <Citation>WHOCC - ATC/DDD Index . Retrieved January 29, 2022, from, https://www.whocc.no/atc_ddd_index/(2022).</Citation>
        </Reference>
        <Reference>
          <Citation>Overview of administrative health datasets — Open Government . Retrieved October 6, 2021, from, https://open.alberta.ca/dataset/overview-of-administrative-health-datasets (2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Government of Canada, S. C . (2021, June 17). Quarterly Demographic Estimates. https://www150.statcan.gc.ca/n1/en/catalogue/91-002-X</Citation>
        </Reference>
        <Reference>
          <Citation>Elbeddini A, Botross A, Gerochi R, et al.Pharmacy response to COVID-19: lessons learnt from Canada. J Pharm Pol Pract 2020; 13(1): 1–8.</Citation>
        </Reference>
        <Reference>
          <Citation>Kostev K, Lauterbach S. Panic buying or good adherence? Increased pharmacy purchases of drugs from wholesalers in the last week prior to Covid-19 lockdown. J Psychiatr 2020; 130: 19–21.</Citation>
        </Reference>
        <Reference>
          <Citation>Hayden JC, Parkin R. The challenges of COVID-19 for community pharmacists and opportunities for the future. Irish J Psychol Med 2020; 37(3): 198–203.</Citation>
        </Reference>
        <Reference>
          <Citation>Pharmacy Benefact . Retrieved October 28, 2021, from, https://www.ab.bluecross.ca/pdfs/pharmacy-benefacts/pharmacy-benefact-847.pdf (2020).</Citation>
        </Reference>
        <Reference>
          <Citation>Mental health and COVID-19 . Retrieved October 6, 2021, from, https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/noncommunicable-diseases/mental-health-and-covid-19 (2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Kar SK, Yasir Arafat SM, Kabir R, et al.Coping with mental health challenges during COVID-19. In: Coronavirus Disease 2019 (COVID-19). Singapore: Springer, 2020, pp. 199–213.</Citation>
        </Reference>
        <Reference>
          <Citation>Hossain MM, Tasnim S, Sultana A, et al.Epidemiology of mental health problems in COVID-19: a review. F1000Res 2020; 9: 639.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Hees S, Fodjo JNS, Wijtvliet V, et al.Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: a multicountry online survey. Epilepsy Behav 2020; 112: 107350, DOI: 10.1016/j.yebeh.2020.107350.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yebeh.2020.107350</ArticleId>
            <ArticleId IdType="pmc">PMC7481834</ArticleId>
            <ArticleId IdType="pubmed">32920373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assenza G, Lanzone J, Brigo F, et al.Epilepsy care in the time of COVID-19 pandemic in Italy: risk factors for seizure worsening. Front Neurology 2020; 11: 737.</Citation>
        </Reference>
        <Reference>
          <Citation>Miller J. J. Serum levels of psychiatric drugs. Psychiatry Times 2014; 19: 49.</Citation>
        </Reference>
        <Reference>
          <Citation>Alberta Precision Laboratories News Releases . Alberta Precision Laboratories, 2020. Retrieved November 15, 2021, from, https://www.albertaprecisionlabs.ca/news/Page13918.aspx.</Citation>
        </Reference>
        <Reference>
          <Citation>Albert DV, Das RR, Acharya JN, et al.The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society Membership. Epilepsy Currents 2020; 20(5): 316–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7502678</ArticleId>
            <ArticleId IdType="pubmed">32942901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elbeddini A, Yeats A. Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract 2020; 13: 1–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6958714</ArticleId>
            <ArticleId IdType="pubmed">31956420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stuhec M, Lah L. Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre–post observational study. Ther Adv Psychopharmacol 2021; 11: 20451253211011007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8072848</ArticleId>
            <ArticleId IdType="pubmed">34025980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grymonpre R, Cheang M, Fraser M, et al.Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 2006; 44: 471–477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16641666</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
